(Q30764147)

English

Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

1 reference

based on heuristic

inferred from title

breast carcinoma

1 reference

based on heuristic

inferred from title

William David Foulkes

object named as

William D Foulkes

9

0 references

author name string

John R Goffin

1

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Pierre O Chappuis

2

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Louis R Bégin

3

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Nora Wong

4

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Jean-Sébastien Brunet

5

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Nancy Hamel

6

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Ann-Josée Paradis

7

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Jeff Boyd

8

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

527-536

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

The contribution of inherited factors to the clinicopathological features and behavior of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

BRCA-associated breast cancer in young women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

The influence of familial and hereditary factors on the prognosis of breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

The p53 tumor suppressor: critical regulator of life & death in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Li-Fraumeni syndrome and the role of the p53 tumor suppressor gene in cancer susceptibility

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Low expression of bcl-2 in Brca1-associated breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

The relative importance of proliferation and cell death in breast cancer growth and response to tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Mechanisms of tamoxifen-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Are Trp53 rescue of Brca1 embryonic lethality and Trp53/Brca1 breast cancer association related?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Correlation between p53 immunostaining patterns and gene sequence mutations in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

BRCA1 Facilitates Stress-induced Apoptosis in Breast and Ovarian Cancer Cell Lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

BRCA1 and BRCA2: from molecular genetics to clinical medicine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Survival and tumor characteristics of German hereditary breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Tumour biological features of BRCA1-induced breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Familial invasive breast cancers: worse outcome related to BRCA1 mutations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Prognostic significance ofp53 mutation in breast cancer: Frequent detection of non-missense mutations by yeast functional assay

2 references

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

https://api.crossref.org/works/10.1002%2FCNCR.11080

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

p53 and survival in early onset breast cancer: analysis of gene mutations, loss of heterozygosity and protein accumulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

p53 protein accumulation and mutations in normal and benign breast tissue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

21 January 2018

BRCA1 mutations in primary breast and ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

7 January 2021

based on heuristic

inferred from DOI database lookup

BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of the p53 tumour suppressor gene in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

7 January 2021

based on heuristic

inferred from DOI database lookup

p53 alteration correlates with negative ER, negative PgR, and high histologic grade in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

7 January 2021

based on heuristic

inferred from DOI database lookup

p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

7 January 2021

based on heuristic

inferred from DOI database lookup

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11080

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.11080

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30764147&oldid=1547477445"